Recurrent Malignant Testicular Germ Cell Tumor Completed Phase 2 Trials for Levoleucovorin (DB11596)

IndicationStatusPhase
DBCOND0028803 (Recurrent Malignant Testicular Germ Cell Tumor)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00957905Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell TumorsTreatment